168 related articles for article (PubMed ID: 32776691)
1. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
Loscocco GG; Malandrino D; Barchiesi S; Berni A; Poggesi L; Guglielmelli P; Vannucchi AM
Int J Lab Hematol; 2020 Dec; 42(6):e270-e273. PubMed ID: 32776691
[No Abstract] [Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH
J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818
[TBL] [Abstract][Full Text] [Related]
3. Cytokine release syndrome in severe COVID-19.
Moore JB; June CH
Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
[No Abstract] [Full Text] [Related]
4. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
[No Abstract] [Full Text] [Related]
5. Hemostasis profile in COVID-19 infection.
Duarte FB; Machado RPG; Lemes RPG; Duarte IA; Duarte BA; Machado CMG; Duarte JVA; Rocha SGMD; Moura ATG; Holanda RARR
Rev Assoc Med Bras (1992); 2020 May; 66(5):571-572. PubMed ID: 32638971
[No Abstract] [Full Text] [Related]
6. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ
Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.
Dewaele K; Claeys R
Blood; 2020 Jun; 135(25):2323. PubMed ID: 32556137
[No Abstract] [Full Text] [Related]
8. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis.
Feld J; Tremblay D; Thibaud S; Kessler A; Naymagon L
Int J Lab Hematol; 2020 Dec; 42(6):773-779. PubMed ID: 32790918
[TBL] [Abstract][Full Text] [Related]
9. Haemophagocytosis in bone marrow aspirates in patients with COVID-19.
Debliquis A; Harzallah I; Mootien JY; Poidevin A; Labro G; Mejri A; Lamarque M; Kuteifan K; Drénou B
Br J Haematol; 2020 Jul; 190(2):e70-e73. PubMed ID: 32529634
[No Abstract] [Full Text] [Related]
10. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
Loscocco GG
Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
[No Abstract] [Full Text] [Related]
11. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.
Bhattacharjee S; Banerjee M; Pal R
Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809
[TBL] [Abstract][Full Text] [Related]
12. Secondary HLH is uncommon in severe COVID-19.
Wood H; Jones JR; Hui K; Mare T; Pirani T; Galloway J; Metaxa V; Benjamin R; Rutherford A; Cain S; Kulasekararaj AG
Br J Haematol; 2020 Sep; 190(5):e283-e285. PubMed ID: 32526046
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
[TBL] [Abstract][Full Text] [Related]
14. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
[TBL] [Abstract][Full Text] [Related]
15. Prone positioning in awake non-ICU patients with ARDS caused by COVID-19.
Taboada M; Rodríguez N; Riveiro V; Baluja A; Atanassoff PG
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):581-583. PubMed ID: 32828956
[No Abstract] [Full Text] [Related]
16. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.
Faguer S; Del Bello A; Abravanel F; Nicolau-Travers ML; Kamar N
Ann Intern Med; 2020 Sep; 173(6):501-503. PubMed ID: 32432518
[No Abstract] [Full Text] [Related]
17. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Chiscano-Camón L; Ruiz-Rodriguez JC; Ruiz-Sanmartin A; Roca O; Ferrer R
Crit Care; 2020 Aug; 24(1):522. PubMed ID: 32847620
[No Abstract] [Full Text] [Related]
18. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
[TBL] [Abstract][Full Text] [Related]
19. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
Opoka-Winiarska V; Grywalska E; Roliński J
BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
[TBL] [Abstract][Full Text] [Related]
20. Haemophagocytic lymphohistiocytosis in COVID-19 cases?
Tveiten H; Aukrust P; Lehne G; Rodriguez JR; Skjønsberg OH
Tidsskr Nor Laegeforen; 2020 Apr; 140(6):. PubMed ID: 32321221
[No Abstract] [Full Text] [Related]
[Next] [New Search]